In a recent study, severely ill patients with CAP and high inflammatory responses received 28-day mortality benefits from corticosteroid therapy. Mortality was significantly lower among patients with septic shock and/or who required invasive mechanical ventilation and who received corticosteroids. Corticosteroid use reduced the 28-day mortality risk in patients who met major severity criteria (hazard ratio [HR], 0.53; 95% CI, 0.29-0.98; P = .043). No benefits were observed with corticosteroid use (HR, 0.88; 95% CI, 0.32-2.36) in patients who did not meet major severity criteria.
Learn more about CAP.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael Stuart Bronze. Rapid Review Quiz: Pneumococcal Infections - Medscape - Mar 11, 2022.